Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  2013-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejpb.2013.08.011PMID 23994244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adult glioblastoma multiforme survival in the temozolomide era: A population‐based analysis of Surveillance, Epidemiology, and End Results registries

  2012cited by this paper
• Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway.

  2012cited by this paper
• Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles.

  2012cited by this paper
• Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.

  2012cited by this paper
• Transport of drugs across the blood-brain barrier by nanoparticles.

  2012cited by this paper
• Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.

  2011cited by this paper
• Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.

  2011cited by this paper
• The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen.

  2011cited by this paper
• Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.

  2011cited by this paper
• Synchrotron SAXS and WAXS study of the interactions of NSAIDs with lipid membranes.

  2011cited by this paper
• Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation.

  2011cited by this paper
• Adipose triglyceride lipase affects triacylglycerol metabolism at brain barriers

  2011cited by this paper
• Physicochemical properties of lipid nanoparticles: Effect of lipid and surfactant composition

  2011cited by this paper
• In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.

  2011cited by this paper
• Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2).

  2010cited by this paper
• The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation.

  2010cited by this paper
• Lipid nanoparticles loaded with 10-hydroxycamptothecin–phospholipid complex developed for the treatment of hepatoma in clinical application

  2010cited by this paper
• In Vivo Methods to Study Uptake of Nanoparticles into the Brain

  2010cited by this paper
• Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.

  2010cited by this paper
• Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship.

  2010cited by this paper
• Alzheimer's disease drug development and the problem of the blood‐brain barrier

  2009cited by this paper
• Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.

  2009cited by this paper
• Surface‐Functionalized Ultrasmall Superparamagnetic Nanoparticles as Magnetic Delivery Vectors for Camptothecin

  2009cited by this paper
• Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

  2009cited by this paper
• Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model.

  2009cited by this paper
• Influence of PEG chain on the complement activation suppression and longevity in vivo prolongation of the PCL biomedical nanoparticles

  2009cited by this paper
• Lipid nanoparticles for parenteral delivery of actives.

  2009cited by this paper
• The FTIR and SAXS studies of influence of a morpholine derivatives on the DMPC-based biological membrane systems

  2009cited by this paper
• Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.

  2008cited by this paper
• Potential of solid lipid nanoparticles in brain targeting.

  2008cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Delivery of nanoparticles to the brain detected by fluorescence microscopy.

  2008cited by this paper
• Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.

  2008cited by this paper
• Poly(amidoamine) dendrimers on lipid bilayers II: Effects of bilayer phase and dendrimer termination.

  2008cited by this paper
• A Photo-Activated Targeting Chemotherapy Using Glutathione Sensitive Camptothecin-Loaded Polymeric Micelles

  2008cited by this paper
• Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

  2008cited by this paper
• Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.

  2008cited by this paper
• Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease

  2008cited by this paper
• Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion

  2008cited by this paper
• Conjugation to increase treatment volume during local therapy: a case study with PEGylated camptothecin.

  2007cited by this paper
• Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering.

  2007cited by this paper
• Solid lipid nanoparticles for targeted brain drug delivery.

  2007cited by this paper
• Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activity.

  2007cited by this paper
• Production of Biofunctionalized Solid Lipid Nanoparticles for Site-specific Drug Delivery

  2007cited by this paper
• Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

  2006cited by this paper
• Progress in liquid crystalline dispersions: Cubosomes

  2005cited by this paper
• Effect of Particle Size and Charge on the Disposition of Lipid Carriers After Intratumoral Injection into Tissue-isolated Tumors

  2004cited by this paper
• Lipoprotein lipase and endothelial lipase expression in mouse brain: regional distribution and selective induction following kainic acid-induced lesion and focal cerebral ischemia.

  2004cited by this paper
• Effect of hydroxypropyl-beta-cyclodextrin-complexation and pH on solubility of camptothecin.

  2004cited by this paper
• Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo.

  2004cited by this paper
• Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.

  2004cited by this paper
• Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughput process.

  2004cited by this paper
• Polymer Delivery of Camptothecin against 9L Gliosarcoma: Release, Distribution, and Efficacy

  2004cited by this paper
• Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability

  2004cited by this paper
• Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters.

  2003cited by this paper
• Drug delivery to the central nervous system: a review.

  2003cited by this paper
• Preparation and Characterization of Camptothecin Solid Lipid Nanoparticles

  2002cited by this paper
• Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.

  2002cited by this paper
• Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier

  2002cited by this paper
• Solid lipid nanoparticles: production, characterization and applications.

  2001cited by this paper
• Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

  2001cited by this paper
• Long-circulating and target-specific nanoparticles: theory to practice.

  2001cited by this paper
• Nanoparticulate systems for brain delivery of drugs.

  2001cited by this paper
• Dependence of Anticancer Activity of Camptothecins on Maintaining Their Lactone Function

  2000cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

  2000cited by this paper
• Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.

  1999cited by this paper
• Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release

  1999cited by this paper
• Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration

  1999cited by this paper
• Leukocyte traffic in the central nervous system: the participants and their roles.

  1999cited by this paper
• Low amounts of PEG-lipid induce cubic phase in phosphatidylethanolamine dispersions.

  1997cited by this paper
• Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles

  1997cited by this paper
• Mechanism of Action of Camptothecin

  1996cited by this paper
• Molecular, cellular, and clinical aspects of the pharmacology of 20(S)camptothecin and its derivatives.

  1995cited by this paper
• Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles).

  1995cited by this paper
• Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats.

  1994cited by this paper
• Camptothecins: from bench research to hospital wards.

  1994cited by this paper
• Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin.

  1991cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

  1966cited by this paper
• Classification of glyceride crystal forms.

  1966cited by this paper
• International Journal of Nanomedicine Dovepress Enhanced Brain Targeting of Temozolomide in Polysorbate-80 Coated Polybutylcyanoacrylate Nanoparticles

  year unknowncited by this paper
• LABORATORY INVESTIGATION- HUMAN/ANIMAL TISSUE

  year unknowncited by this paper

• The effects of cyclic peptide [R4W4] in combination with first-line therapy on the survival of Mycobacterium avium

  2025cites this paper
• Different preparation and characterization techniques of lipid nanoparticle and its application as drug carrier

  2025cites this paper
• Advances in Elemene Nanodelivery Systems: From Material Design to Disease Treatment

  2025cites this paper
• Infusion and iontophoresis for directional delivery of compounds to the brain

  2025cites this paper
• Optimization and Characterization of Aspirin‐ and Ibuprofen‐Loaded Lipid‐Based Nanoparticle Synthesis for Antibacterial Activity and Cytotoxic Effect

  2025cites this paper
• A comprehensive review on lipid-based nanoparticles via nose to brain targeting as a novel approach

  2024cites this paper
• Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges

  2024cites this paper
• Advancements in nanotheranostics for glioma therapy

  2024cites this paper
• Lipid Nanoparticles for Brain Tumor Theranostics: Challenges and Status.

  2024cites this paper
• Future-Oriented Nanosystems Composed of Polyamidoamine Dendrimer and Biodegradable Polymers as an Anticancer Drug Carrier for Potential Targeted Treatment

  2024cites this paper
• Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer

  2024cites this paper
• Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

  2024cites this paper
• Unraveling the Therapeutic Prospects of Solid Lipid Nanoparticles for the Treatment of Parasitic Diseases

  2024cites this paper
• Curcumin/TGF-β1 siRNA loaded solid lipid nanoparticles alleviate cerebral injury after intracerebral hemorrhage by transnasal brain targeting.

  2024cites this paper
• Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway

  2024cites this paper
• Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges

  2024cites this paper
• Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies

  2024cites this paper
• Intranasal delivery of Chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: a comprehensive review of advanced strategies for CNS targeting

  2024cites this paper
• Nanomodulators That Target Alzheimer’s Disease: A Review

  2024cites this paper
• Polymersomes for Sustained Delivery of a Chalcone Derivative Targeting Glioblastoma Cells

  2024cites this paper
• Development of solid lipid nanoparticles-loaded drugs in parasitic diseases

  2024cites this paper
• The Role of Nanotechnologies in Brain Tumors.

  2023cites this paper
• Recent progress in nanomedicines for imaging and therapy of brain tumors.

  2023cites this paper
• Molecularly imprinted nanoparticles as drug carriers to the brain

  2023cites this paper
• PEGylated bottom-up synthesized graphene nanoribbons loaded with camptothecin as potential drug carriers

  2023cites this paper
• Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas

  2023cites this paper
• Polyelectrolyte nanoparticles based on poly[N-(2-hydroxypropyl)methacrylamide-block-poly(N-(3-aminopropyl)methacrylamide] copolymers for delivery of heparin-binding proteins

  2023cites this paper
• Nanoparticles loaded with pharmacologically active plant-derived natural products: Biomedical applications and toxicity.

  2023cites this paper
• Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: Roles of preparation methods, lipid composition, transitional stability, and release profiles in nanocarriers’ development

  2023cites this paper
• Biphasic nature of lipid bilayers assembled on silica nanoparticles and evidence for an interdigitated phase.

  2023cites this paper
• Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

  2022cites this paper
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• Preparation and Characterization of Magnetic Solid Lipid Nanoparticles as a Targeted Drug Delivery System for Doxorubicin

  2022cites this paper
• Nanocarriers and their Types for Targeted Drug Delivery

  2022cites this paper
• The role of lipid based nanoparticles in brain targeted drug delivery system: An overview

  2022cites this paper
• Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer’s disease

  2022cites this paper
• Solid Lipid Nanoparticles-Based Drug and Gene Delivery to Macrophages

  2022cites this paper
• Small Molecules of Marine Origin as Potential Anti-Glioma Agents

  2021cites this paper
• Lipid Nanoparticles for Drug Delivery

  2021cites this paper
• Cancer Nanotechnology for Drug Targeting and Delivery Approaches

  2021cites this paper
• Lipid nanostructures for targeting brain cancer

  2021cites this paper
• Recent advancement and development in nanoneurology

  2021cites this paper
• Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB

  2021cites this paper
• Brain-targeted, drug-loaded solid lipid nanoparticles against glioblastoma cells in culture.

  2021cites this paper
• A Biophysical Insight of Camptothecin Biodistribution: Towards a Molecular Understanding of Its Pharmacokinetic Issues

  2021cites this paper
• Nanoparticulate Carriers—Versatile Delivery Systems

  2021cites this paper
• Phyto-drug conjugated nanomaterials enhance apoptotic activity in cancer.

  2021cites this paper
• RGD-decorated solid lipid nanoparticles enhanced tumor targeting, penetration and anticancer effect of asiatic acid.

  2020cites this paper
• Pharmacokinetics and brain distribution studies of perphenazine-loaded solid lipid nanoparticles

  2020cites this paper
• Nanoscience in Medicine Vol. 1

  2020cites this paper
• A comprehensive review of nano drug delivery system in the treatment of CNS disorders

  2020cites this paper
• Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor

  2020cites this paper
• Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook.

  2020cites this paper
• Oral and Intra-nasal Administration of Nanoparticles in the Cerebral Ischemia Treatment in Animal Experiments: Considering its Advantages and Disadvantages

  2020cites this paper
• Role of Nanomedicine in Treatment of Brain Cancer

  2020cites this paper
• Nanomedicine in the Ttreatment of Pathologies of the Central Nervous System Advances in Nanomedicine

  2020cites this paper
• Solid Lipid Nanoparticles: A Multidimensional Drug Delivery System

  2020cites this paper
• Development of Polymeric Nanocarriers for Brain Targeted Delivery of Atorvastatin: A Quality-By-Design Approach

  2020cites this paper
• Nanoparticle brain delivery: a guide to verification methods.

  2020cites this paper
• Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours

  2020cites this paper
• Bioinspired Biomaterials: Advances in Tissue Engineering and Regenerative Medicine

  2020cites this paper
• Protein-Based Drug Delivery in Brain Tumor Therapy.

  2020cites this paper
• Surface-Functionalized Lipid Nanoparticles for Site-Specific Drug Delivery

  2019cites this paper
• Synthesis, characterization, and cytotoxicity assessment of N-acetyl-l-cysteine capped ZnO nanoparticles as camptothecin delivery system.

  2019cites this paper
• A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders.

  2019cites this paper
• Surface Modification of Nanoparticles for Targeted Drug Delivery

  2019cites this paper
• Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles.

  2019cites this paper
• Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review of the Effect of Physicochemical Formulation Factors in the Optimization Process, Different Preparation Technique, Characterization, and Toxicity

  2019cites this paper
• Properties and therapeutic potential of solid lipid nanoparticles and nanostructured lipid carriers as promising colloidal drug delivery systems

  2019cites this paper
• A new approach for drug targeting to the central nervous system

  2019cites this paper
• Surface Modified Solid Lipid Nanoparticles for Brain Cancer Treatment

  2019influential citation
• Strategies in overcoming the challenges of cytotoxic agents using smart colloidal solid lipid nanoparticles and nanostructured lipid carriers - A review

  2019cites this paper
• Lipid Based Nanoparticles: Current Strategies for Brain Tumor Targeting

  2019cites this paper
• Understanding the cellular uptake and biodistribution of a dual-targeting carrier based on redox-sensitive hyaluronic acid-ss-curcumin micelles for treating brain glioma.

  2019cites this paper
• Sustained delivery of olanzapine from sunflower oil-based polyol-urethane nanoparticles synthesised through a cyclic carbonate ring-opening reaction.

  2019cites this paper
• Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Emerging Lipid Based Drug Delivery Systems

  2019cites this paper
• Nanoformulations for glioblastoma multiforme: a new hope for treatment.

  2019cites this paper
• Solid Lipid Based Nano-particulate Formulations in Drug Targeting

  2019cites this paper
• Methods to Quantify Nanomaterial Association with, and Distribution Across, the Blood-Brain Barrier In Vivo.

  2018cites this paper
• Dimeric camptothecin derived phospholipid assembled liposomes with high drug loading for cancer therapy.

  2018cites this paper
• POTENTIAL OF SOLID LIPID NANOPARTICLES IN BRAIN CANCER TREATMENT

  2018cites this paper
• Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation

  2018cites this paper
• Redox sensitive lipid‐camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery

  2018cites this paper
• Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.

  2018cites this paper
• Nanoparticles drug-delivery systems and antiangiogenic approaches in the treatment of gliomas

  2018cites this paper
• The role of nanoparticles in the improvement of systemic anticancer drug delivery.

  2018cites this paper
• An egg yolk’s phospholipid-pennyroyal nootropic nanoformulation modulates monoamino oxidase-A (MAO-A) activity in SH-SY5Y neuronal model

  2018cites this paper
• Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer

  2018cites this paper
• Phytochemical based nanomedicines against cancer: current status and future prospects

  2017cites this paper
• Lipid-Based Nanocarriers in Cancer Therapy

  2017cites this paper
• Nanoscience in Targeted Brain Drug Delivery

  2017cites this paper
• Nanocarriers for Effective Brain Drug Delivery.

  2017cites this paper
• Design and preparation of biomimetic and bioinspired materials

  2017cites this paper
• Antimicrobial Nanostructures for Neurodegenerative Infections

  2017cites this paper
• Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles.

  2017cites this paper
• Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases

  2017cites this paper
• Uptake and distribution of ultrafine nanoparticles and microemulsions from the nasal mucosa

  2017cites this paper
• Peptide grafted and self-assembled poly(γ-glutamic acid)-phenylalanine nanoparticles targeting camptothecin to glioma.

  2017cites this paper
• Recent advances in the treatment of glioblastoma multiforme by inhibiting angiogenesis and using nanocarrier systems

  2017cites this paper
• Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.

  2017cites this paper